VistaGen Stocks Neuropsychiatry Pipeline And Takes Aim At Depression Market

Shawn Singh, CEO of VistaGen, a growing Silicon Valley-based biotech focused on psychiatry and neurological drug development, outlines the company’s strategy for getting to market in the US and expanding its pipeline into new areas.